The germinal center (GC) is a site where somatic hypermutation and clonal selection are coupled for antibody affinity maturation against infections. However, how GCs are formed and regulated is incompletely understood. Here, we identified an unexpected role of Tank-binding kinase-1 (TBK1) as a crucial B cell–intrinsic factor for GC formation. Using immunization and malaria infection models, we show that TBK1-deficient B cells failed to form GC despite normal Tfh cell differentiation, although some malaria-infected B cell–specific TBK1-deficient mice could survive by GC-independent mechanisms. Mechanistically, TBK1 phosphorylation elevates in B cells during GC differentiation and regulates the balance of IRF4/BCL6 expression by limiting CD40 and BCR activation through noncanonical NF-κB and AKTT308 signaling. In the absence of TBK1, CD40 and BCR signaling synergistically enhanced IRF4 expression in Pre-GC, leading to BCL6 suppression, and therefore failed to form GCs. As a result, memory B cells generated from TBK1-deficient B cells fail to confer sterile immunity upon reinfection, suggesting that TBK1 determines B cell fate to promote long-lasting humoral immunity.
Skip Nav Destination
Article navigation
7 February 2022
Article|
December 15 2021
B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice
Michelle S.J. Lee
,
Michelle S.J. Lee
(Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Validation, Visualization, Writing - original draft, Writing - review & editing)
1
Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
12
International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Takeshi Inoue
,
Takeshi Inoue
(Investigation, Methodology)
2
Laboratory of Lymphocyte Differentiation, Immunology Frontier Research Center, Osaka University, Osaka, Japan
Search for other works by this author on:
Wataru Ise
,
Wataru Ise
(Investigation)
2
Laboratory of Lymphocyte Differentiation, Immunology Frontier Research Center, Osaka University, Osaka, Japan
Search for other works by this author on:
Julia Matsuo-Dapaah
,
Julia Matsuo-Dapaah
(Data curation, Formal analysis)
1
Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Search for other works by this author on:
James B. Wing
,
James B. Wing
(Investigation)
3
Laboratory of Human Immunology (Single Cell Immunology), Immunology Frontier Research Center, Osaka University, Osaka, Japan
4
Human Single Cell Immunology Team, Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan
Search for other works by this author on:
Burcu Temizoz
,
Burcu Temizoz
5
Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
12
International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Kouji Kobiyama
,
Kouji Kobiyama
(Resources)
5
Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
12
International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Tomoya Hayashi
,
Tomoya Hayashi
(Resources)
5
Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
12
International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Ashwini Patil
,
Ashwini Patil
(Formal analysis, Software)
6
Combinatics Inc., Tokyo, Japan
Search for other works by this author on:
Shimon Sakaguchi
,
Shimon Sakaguchi
(Resources)
7
Laboratory of Experimental Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan
Search for other works by this author on:
A. Katharina Simon
,
A. Katharina Simon
(Conceptualization)
8
The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
Search for other works by this author on:
Jelena S. Bezbradica
,
Jelena S. Bezbradica
(Resources)
8
The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
Search for other works by this author on:
Satoru Nagatoishi
,
Satoru Nagatoishi
(Resources, Validation)
9
Research Platform Office, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Kouhei Tsumoto
,
Kouhei Tsumoto
(Resources)
9
Research Platform Office, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
10
Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Jun-Ichiro Inoue
,
Jun-Ichiro Inoue
(Conceptualization)
9
Research Platform Office, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Shizuo Akira
,
Shizuo Akira
(Resources)
11
Immunology Frontier Research Center, Osaka University, Osaka, Japan
Search for other works by this author on:
Tomohiro Kurosaki
,
Tomohiro Kurosaki
(Supervision)
2
Laboratory of Lymphocyte Differentiation, Immunology Frontier Research Center, Osaka University, Osaka, Japan
Search for other works by this author on:
Ken J. Ishii
,
5
Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
11
Immunology Frontier Research Center, Osaka University, Osaka, Japan
12
International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Ken J. Ishii: kenishii@ims.u-tokyo.ac.jp
Search for other works by this author on:
Cevayir Coban
(Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing - original draft, Writing - review & editing)
1
Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
11
Immunology Frontier Research Center, Osaka University, Osaka, Japan
12
International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Correspondence to Cevayir Coban: ccoban@ims.u-tokyo.ac.jp
Search for other works by this author on:
Michelle S.J. Lee
Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Validation, Visualization, Writing - original draft, Writing - review & editing
1
Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
12
International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Takeshi Inoue
Investigation, Methodology
2
Laboratory of Lymphocyte Differentiation, Immunology Frontier Research Center, Osaka University, Osaka, Japan
Wataru Ise
Investigation
2
Laboratory of Lymphocyte Differentiation, Immunology Frontier Research Center, Osaka University, Osaka, Japan
Julia Matsuo-Dapaah
Data curation, Formal analysis
1
Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
James B. Wing
Investigation
3
Laboratory of Human Immunology (Single Cell Immunology), Immunology Frontier Research Center, Osaka University, Osaka, Japan
4
Human Single Cell Immunology Team, Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan
Burcu Temizoz
5
Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
12
International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Kouji Kobiyama
Resources
5
Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
12
International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Tomoya Hayashi
Resources
5
Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
12
International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Ashwini Patil
Formal analysis, Software
6
Combinatics Inc., Tokyo, Japan
Shimon Sakaguchi
Resources
7
Laboratory of Experimental Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan
A. Katharina Simon
Conceptualization
8
The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
Jelena S. Bezbradica
Resources
8
The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
Satoru Nagatoishi
Resources, Validation
9
Research Platform Office, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Kouhei Tsumoto
Resources
9
Research Platform Office, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
10
Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan
Jun-Ichiro Inoue
Conceptualization
9
Research Platform Office, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Shizuo Akira
Resources
11
Immunology Frontier Research Center, Osaka University, Osaka, Japan
Tomohiro Kurosaki
Supervision
2
Laboratory of Lymphocyte Differentiation, Immunology Frontier Research Center, Osaka University, Osaka, Japan
5
Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
11
Immunology Frontier Research Center, Osaka University, Osaka, Japan
12
International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Cevayir Coban
Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing - original draft, Writing - review & editing
1
Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
11
Immunology Frontier Research Center, Osaka University, Osaka, Japan
12
International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Correspondence to Cevayir Coban: ccoban@ims.u-tokyo.ac.jp
Ken J. Ishii: kenishii@ims.u-tokyo.ac.jp
Disclosures: A. Patil reported personal fees from Combinatics Inc. outside the submitted work. No other disclosures were reported.
Received:
June 24 2021
Revision Received:
October 20 2021
Accepted:
November 17 2021
Online Issn: 1540-9538
Print Issn: 0022-1007
Funding
Funder(s):
Japan Science and Technology Agency
Funder(s):
Japan Agency for Medical Research and Development
- Award Id(s): 17fm0208021h0001
Funder(s):
International Joint Research Project
Funder(s):
Mitsubishi UFJ
Funder(s):
Institute of Medical Science, University of Tokyo
Funder(s):
Japan Society for the Promotion of Science
- Award Id(s): JP19K16833,JP 20K16234
© 2021 Lee et al.
2021
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
J Exp Med (2022) 219 (2): e20211336.
Article history
Received:
June 24 2021
Revision Received:
October 20 2021
Accepted:
November 17 2021
Citation
Michelle S.J. Lee, Takeshi Inoue, Wataru Ise, Julia Matsuo-Dapaah, James B. Wing, Burcu Temizoz, Kouji Kobiyama, Tomoya Hayashi, Ashwini Patil, Shimon Sakaguchi, A. Katharina Simon, Jelena S. Bezbradica, Satoru Nagatoishi, Kouhei Tsumoto, Jun-Ichiro Inoue, Shizuo Akira, Tomohiro Kurosaki, Ken J. Ishii, Cevayir Coban; B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice. J Exp Med 7 February 2022; 219 (2): e20211336. doi: https://doi.org/10.1084/jem.20211336
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your Institution
1,980
Views
0
Citations
Advertisement